Fixation Buffer

Product Details

Storage & Handling

This buffer solution should be stored between 2°C and 8°C.

Application

ICFC - Quality tested
ICC

Recommended Usage

For cell fixation, use 250 µL fixation buffer per tube and leave it in the dark for 20 minutes at room temperature. It is recommended that the reagent be titrated for optimal performance for each application. For the fixation procedure, please refer to the "Intracellular Cytokine Staining Protocol" under "Support" on BioLegend's website.
Caution: This buffer contains paraformaldehyde, which is toxigenic and mutagenic. Please handle with caution and wear gloves, lab coat and necessary protection to avoid direct body contacts.

Application Notes

This 1X PBS solution contains 4% paraformaldehyde, which is toxic and is a suspected carcinogen. Contact with eyes, skin and mucous membranes should be avoided.

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells and to perform phospho-flow in our Scientific Poster Library.

Application References

(PubMed link indicates BioLegend citation)

1. Kang YJ, et al. 2007. Nature Immunol. 8:601.
2. Kenna TJ, et al. 2010. J. Immunol. 184:598. PubMed
3. Sullivan BP, et al. 2010. Am J Pathol. 177:2837. PubMed
4. del Rio ML, et al. 2011.Transplantation. 92:1085. PubMed
5. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
6. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
7. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
8. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed

Product Citations

1. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
2. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
3. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
4. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
5. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
6. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
7. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
8. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
9. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
10. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
11. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
12. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
13. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
14. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
15. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
16. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
17. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
18. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
19. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
20. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
21. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
22. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
23. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
24. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
25. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
26. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
27. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
28. Chan L, et al. 2022. Cells. 12: . PubMed
29. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
30. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
31. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
32. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
33. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
34. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
35. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
36. Zander R, et al. 2022. Immunity. 55:475. PubMed
37. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
38. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
39. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
40. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
41. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
42. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
43. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
44. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
45. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
46. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
47. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
48. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
49. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
50. Wang H, et al. 2023. Nature. 615:339. PubMed
51. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
52. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
53. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
54. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
55. Wang Y, et al. 2023. iScience. 26:106630. PubMed
56. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
57. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
58. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
59. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
60. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
61. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
62. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
63. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
64. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
65. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
66. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
67. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
68. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
69. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
70. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
71. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
72. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
73. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
74. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
75. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
76. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
77. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
78. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
79. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
80. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
81. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
82. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
83. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
84. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
85. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
86. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
87. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
88. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
89. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
90. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
91. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
92. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
93. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
94. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
95. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
96. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
97. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
98. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
99. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
100. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
101. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
102. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
103. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
104. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
105. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
106. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
107. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
108. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
109. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
110. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
111. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
112. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
113. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
114. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
115. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
116. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
117. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
118. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
119. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
120. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
121. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
122. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
123. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
124. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
125. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
126. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
127. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
128. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
129. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
130. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
131. Yang J, et al. 2022. Microbiome. 10:149. PubMed
132. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
133. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
134. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
135. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
136. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
137. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
138. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
139. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
140. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
141. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
142. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
143. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
144. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
145. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
146. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
147. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
148. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
149. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
150. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
151. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
152. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
153. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
154. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
155. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
156. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
157. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
158. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
159. Ma K, et al. 2022. iScience. 25:104347. PubMed
160. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
161. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
162. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
163. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
164. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
165. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
166. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
167. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
168. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
169. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
170. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
171. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
172. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
173. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
174. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
175. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
176. Woo MS, et al. 2021. J Exp Med. :218. PubMed
177. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
178. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
179. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
180. Zhao X, et al. 2022. iScience. 25:104690. PubMed
181. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
182. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
183. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
184. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
185. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
186. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
187. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
188. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
189. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
190. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
191. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
192. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
193. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
194. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
195. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
196. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
197. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
198. Sun Y, et al. 2022. iScience. 25:104846. PubMed
199. Wang X, et al. 2022. Elife. 11:. PubMed
200. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
201. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
202. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
203. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
204. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
205. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
206. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
207. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
208. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
209. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
210. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
211. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
212. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
213. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
214. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
215. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed

See More

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID

NA

Documentation

• Technical Data Sheet (pdf)
• Certificate of Analysis
• Safety Data Sheet

Reviews

Related Protocols

• Surface and Intracellular Cytokine Staining for Flow Cytometry - Video
• Intracellular Flow Cytometry Staining Protocol

Related Pages & Pathways

Related FAQs

Certificate of Analysis